Biocon Limited has informed the Exchange about Schedule of meet
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biocon has informed the stock exchanges that its management will participate in the Goldman Sachs India Pharma Corporate Days scheduled for March 6, 2026. The interaction will be a virtual group meeting with analysts and institutional investors. The company has clarified that no unpublished price-sensitive information (UPSI) will be shared during the meeting. The schedule is subject to change based on investor or company exigencies.
This is a routine compliance disclosure and does not carry any material impact on the stock. Participation in a Goldman Sachs pharma conference signals continued investor engagement but no new business or financial information is being shared at this stage.